Free Trial

Q32 Bio (QTTB) Institutional Ownership

Q32 Bio logo
$3.43 -0.07 (-2.00%)
(As of 12/17/2024 ET)

Institutional Ownership Changes (13F Filings) for Q32 Bio (NASDAQ:QTTB)

Current
Institutional Ownership
Percentage
31.32%
Number of
Institutional Buyers
(last 12 months)
26
Total
Institutional Inflows
(last 12 months)
$102.52M
Number of
Institutional Sellers
(last 12 months)
0
Get QTTB Insider Trade Alerts

Want to know when executives and insiders are buying or selling Q32 Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

QTTB Institutional Buying and Selling by Quarter

Q32 Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/27/2024 Franklin Resources Inc.4,857$225K0.0%N/A0.040%
11/19/2024 Barclays PLC10,443$465K0.0%+105.2%0.086%
11/16/2024 Geode Capital Management LLC131,768$5.88M0.0%+22.4%1.082%
11/15/2024 Barclays PLC10,443$465K0.0%+105.2%0.086%
11/15/2024 Jane Street Group LLC16,437$733K0.0%N/A0.135%
11/15/2024 State Street Corp110,164$4.92M0.0%+35.5%0.904%
11/15/2024 Point72 Asset Management L.P.76,685$3.42M0.0%N/A0.630%
11/14/2024 Eventide Asset Management LLC190,000$8.48M0.1%N/A1.560%
11/14/2024 MetLife Investment Management LLC3,563$159K0.0%N/A0.029%
11/13/2024 BNP Paribas Financial Markets1,298$58K0.0%+199.1%0.011%
11/13/2024 FMR LLC426,302$19.02M0.0%+137.3%3.500%
10/23/2024 Values First Advisors Inc.741$33K0.0%N/A0.006%
8/13/2024 Ensign Peak Advisors Inc64,481$1.16M0.0%+150.6%0.540%
8/9/2024 Renaissance Technologies LLC14,764$265K0.0%N/A0.124%
8/9/2024 Harvard Management Co. Inc.162,965$2.93M0.2%N/A1.365%
8/1/2024 Rhumbline Advisers7,658$137K0.0%+11,681.5%0.064%
7/26/2024 Bank of New York Mellon Corp17,569$315K0.0%N/A0.147%
5/17/2024 Ikarian Capital LLC22,335$381K0.0%N/A0.685%
5/15/2024 ARCH Venture Management LLC320,482$5.46M6.5%N/A9.831%
5/15/2024 Affinity Asset Advisors LLC27,777$473K0.1%N/A0.852%
5/14/2024 Platinum Investment Management Ltd.109,964$1.87M0.1%N/A3.373%
5/10/2024 Acadian Asset Management LLC3,695$62K0.0%N/A0.113%
5/10/2024 Vanguard Group Inc.107,752$1.84M0.0%N/A3.305%
5/6/2024 Atlas Venture Life Science Advisors LLC2,092,106$35.65M3.3%N/A64.254%
5/3/2024 Carlyle Group Inc.1,102,741$18.07M1.1%N/A33.826%
4/23/2024 BML Capital Management LLC24,894$424K0.3%N/A0.764%
4/22/2024 Vivo Capital LLC370,068$6.31M0.5%N/A11.366%
(Data available from 1/1/2016 forward)

QTTB Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of QTTB shares?

During the previous two years, 26 institutional investors and hedge funds held shares of Q32 Bio. The most heavily invested institutionals were Atlas Venture Life Science Advisors LLC ($35.65M), FMR LLC ($19.02M), Carlyle Group Inc. ($18.07M), Eventide Asset Management LLC ($8.48M), Vivo Capital LLC ($6.31M), Geode Capital Management LLC ($5.88M), and ARCH Venture Management LLC ($5.46M).Learn more on QTTB's institutional investors.

What percentage of Q32 Bio stock is owned by institutional investors?

31.32% of Q32 Bio stock is owned by institutional investors. Learn more on QTTB's institutional investor holdings.

Which institutional investors have been buying Q32 Bio stock?

Of the 26 institutional investors that purchased Q32 Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Atlas Venture Life Science Advisors LLC ($2.09M), Carlyle Group Inc. ($1.10M), Vivo Capital LLC ($370.07K), ARCH Venture Management LLC ($320.48K), FMR LLC ($246.66K), Eventide Asset Management LLC ($190K), and Harvard Management Co. Inc. ($162.97K).

How much institutional buying is happening at Q32 Bio?

Institutional investors have bought a total of 5,026,951 shares in the last 24 months. This purchase volume represents approximately $102.52M in transactions.



This page (NASDAQ:QTTB) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners